Omnicell, Inc. (OMCL) Stock Grade

About Omnicell, Inc.'s fundamentals

Omnicell is a $2.1 billion healthcare equipment and services company experiencing modest revenue growth of 6.5% year-over-year, though profitability metrics are notably constrained. The company operates with an extremely thin net margin of 0.2% and generates minimal return on equity at 0.2%, indicating that while the business generates revenue, it converts very little to actual profit. The P/E ratio of 1,014.7 is exceptionally high, reflecting either a small earnings base or market expectations of significant future profitability improvements. The company does not currently pay a dividend.